NGL Fine - Chem Investor Presentation: Key Takeaways
Q2FY27 revenue ₹158.71 Cr (+31.97% YoY), EBITDA ₹28.06 Cr (17.68% margin), PAT ₹16.25 Cr (+68.74% YoY). Phase II plant commissioned; regulatory build-out ongoing.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Q2FY27 revenue ₹158.71 Cr (+31.97% YoY), EBITDA ₹28.06 Cr (17.68% margin), PAT ₹16.25 Cr (+68.74% YoY). Phase II plant commissioned; regulatory build-out ongoing.
NGL Fine - Chem Ltd reported revenue from operations of ₹158.7 Cr (+31.9% YoY) and net profit of ₹16.2 Cr (+68.8% YoY) for Q2 FY27.
NGL Fine-Chem will hold a board meeting on November 6, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after results.
NGL Fine Chem Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Listing Regulations.
NGL Fine Chem received SEBI exemption for inter-se transfer of 29.09% promoter shares to family trusts. Total promoter holding remains unchanged.